Loading company…
Palo Alto-based Telik is a biotechnology company developing novel cancer therapeutics.
Headquartered in Palo Alto, US, Telik is a biotechnology firm focused on cancer therapeutics, drug discovery and development. Its pipeline includes several candidates for upcoming clinical trials, and it plans to expand into Asia and Latin America by 2025. The company has completed 2 deals, the most recent an exit by Advent International in March 2002.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in